EFFECTS OF CYP2D6 AND CYP3A5 GENOTYPES ON THE PLASMA CONCENTRATIONS OF RISPERIDONE AND 9-HYDROXYRISPERIDONE IN KOREAN SCHIZOPHRENIC PATIENTS.

被引：0
|
作者：
Kang, R. [1 ]
Jung, S. [2 ]
Kim, K. [3 ]
Lee, D. [2 ]
Cho, H. [2 ]
Jung, B. [2 ]
Lee, M. [1 ]
Park, J. [3 ]
机构：
[1] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[2] Yangsan Neuropsychiat Hosp, Dept Psychiat, Yangsan, South Korea
[3] Korea Univ, Coll Med, Dept Clin Pharmacol & Toxicol, Seoul 136705, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [21] Effects of CYP2C19, CYP2D6 and CYP3A5 polymorphisms on the pharmacokinetics of cilostazol in healthy Korean subjects.
    Lee, S.
    Bae, J.
    Jang, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S68 - S68
  • [22] Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
    Berecz, R
    Llerena, A
    de la Rubia, A
    Gómez, J
    Kellermann, M
    Dorado, P
    Degrell, I
    PHARMACOPSYCHIATRY, 2002, 35 (06) : 231 - 234
  • [23] CYP2D6, CYP2C19, CYP2C9 and CYP3A5 polymorphism in the Spanish population
    Llovo, R.
    Tudoli, I
    Carril, J. C.
    Fernandez-Novoa, L.
    Seoane, S.
    Cacabelos, R.
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2009, 2009, : 53 - 57
  • [24] Impact of CYP2D6, CYP3A5, and ABCB1 Polymorphisms on Plasma Concentrations of Donepezil and Its Metabolite in Patients With Alzheimer Disease
    Kagawa, Yoshiyuki
    Yamamoto, Yoshiaki
    Ueno, Ayami
    Maeda, Toshio
    Obi, Tomokazu
    THERAPEUTIC DRUG MONITORING, 2021, 43 (03) : 429 - 435
  • [25] Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients
    Roh, HK
    Chung, JY
    Oh, DY
    Park, CS
    Svensson, JO
    Dahl, ML
    Bertilsson, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (03) : 265 - 271
  • [26] Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
    Kneller, Lisa Alina
    Hempel, Georg
    PHARMACEUTICAL RESEARCH, 2020, 37 (06)
  • [27] Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients
    Jung, SM
    Kim, KA
    Cho, HK
    Jung, IG
    Park, PW
    Byun, WT
    Park, JY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (05) : 520 - 528
  • [28] Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
    Lisa Alina Kneller
    Georg Hempel
    Pharmaceutical Research, 2020, 37
  • [29] Relationship of CYP2D6, CYP3A, POR, and ABCB1 Genotypes With Galantamine Plasma Concentrations
    Noetzli, Muriel
    Guidi, Monia
    Ebbing, Karsten
    Eyer, Stephan
    Zumbach, Serge
    Giannakopoulos, Panteleimon
    von Gunten, Armin
    Csajka, Chantal
    Eap, Chin B.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (02) : 270 - 275
  • [30] Effects of CYP3A5 genetic polymorphism on the pharmacokinetics of tamsulosin in subjects with with CYP2D6*10/*10
    Byeon, Ji-Yeong
    Jang, Choon-Gon
    Lee, Seok-Yong
    PHARMACOTHERAPY, 2012, 32 (10): : E236 - E236
12345